Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

  1. Vermersch, P.
  2. Brieva-Ruiz, L.
  3. Fox, R.J.
  4. Paul, F.
  5. Ramio-Torrenta, L.
  6. Schwab, M.
  7. Moussy, A.
  8. Mansfield, C.
  9. Hermine, O.
  10. Maciejowski, M.
Aldizkaria:
Neurology(R) neuroimmunology & neuroinflammation

ISSN: 2332-7812

Argitalpen urtea: 2022

Alea: 9

Zenbakia: 3

Mota: Artikulua

DOI: 10.1212/NXI.0000000000001148 GOOGLE SCHOLAR lock_openSarbide irekia editor

Objetivos de desarrollo sostenible

Datuen iturria: Scopus